Development milestones

Adalat – a successful antihypertensive therapy for more than 30 years

Adalat was approved for the treatment of hypertension in 1981. Several formulations of Adalat have been developed, including Capsule and Retard - the GastroIntestinal Therapeutic System (GITS) formulation was launched in 1991.

Clinical trials continue to provide data guiding the optimum use of Adalat.




CCB, calcium channel blocker; ISH, isolated systolic hypertension.

* studies conducted with Adalat CR